Protein phosphorylation and APP metabolism

• Published in: Neurochemical research Vol. 28; no. 10; pp. 1553 - 1561
• Main Authors: DA CRUZ E SILVA, Edgar F, DA CRUZ E SILVA, Odete A. B
• Format: Journal Article
• Language: English
• Published: New York, NY Springer 01-10-2003; Springer Nature B.V
• Subjects: Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Amyloid beta-Peptides - biosynthesis; Amyloid beta-Protein Precursor - metabolism; Animals; Biological and medical sciences; Fundamental and applied biological sciences. Psychology; Humans; Phosphorylation; Signal Transduction; Vertebrates: nervous system and sense organs; Phosphorylation; kinase; phosphatase; Metabolism; signal transduction; APP metabolism
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1023/A:1025630627319

Numerous lines of evidence place signal transduction cascades at the core of many processes having a direct role in neurodegeneration and associated disorders. Key players include neurotransmitters, growth factors, cytokines, hormones, and even binding and targeting proteins. Indeed, abnormal phosphorylation of key control proteins has been detected in many cases and is thought to underlie the associated cellular dysfunctions. Several signaling cascades have been implicated, affecting processes as varied as protein processing, protein expression, and subcellular protein localization, among others. The Alzheimer's amyloid precursor protein (APP) is a phosphoprotein, with well-defined phosphorylation sites but whose function is not clearly understood. The factors and pathways regulating the processing of APP have been particularly elusive, both in normal ageing and the Alzheimer's disease (AD) condition. Not surprisingly, the physiological function(s) of the protein remain(s) to be elucidated, although many hypotheses have been advanced. Nonetheless, considerable data has accumulated over the last decade, placing APP in key positions to be modulated both directly and indirectly by phosphorylation and phosphorylation-dependent events. The pathological end product of APP processing is the main proteinaceous component of the hallmark senile plaques found in the brains of AD patients, that is, a toxic peptide termed Abeta. In this minireview we address the importance of phosphorylation and signal transduction cascades in relation to APP processing and Abeta production. The possible use of the identified molecular alterations as therapeutic targets is also addressed.